ACUTE MYELOBLASTIC-LEUKEMIA WITHOUT PHILADELPHIA-CHROMOSOME DEVELOPING AFTER INTERFERON THERAPY FOR CHRONIC MYELOCYTIC-LEUKEMIA WITH PHILADELPHIA-CHROMOSOME
被引:18
|
作者:
OHTSUKA, E
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
OHTSUKA, E
KIKUCHI, H
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
KIKUCHI, H
ABE, Y
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
ABE, Y
MORIYAMA, K
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
MORIYAMA, K
OHNO, E
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
OHNO, E
HIROTA, K
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
HIROTA, K
TEZONO, K
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
TEZONO, K
NASU, M
论文数: 0引用数: 0
h-index: 0
机构:Second Department of Internal Medicine, Oita Medical University, Oita
NASU, M
机构:
[1] Second Department of Internal Medicine, Oita Medical University, Oita
CML;
PHILADELPHIA CHROMOSOME;
INTERFERON;
THERAPY-RELATED LEUKEMIA;
TRISOMY 8 AND TRISOMY 11;
D O I:
10.1111/j.1365-2141.1995.tb05223.x
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
We report a patient who developed Philadelphia chromosome negative acute myeloblastic leukaemia with trisomy 8 and trisomy 11 after receiving treatment with allrylating agents and interferon for chronic myelocytic leukaemia positive for Philadelphia chromosome. Leukaemic cells were positive for myeloperoxidase and expressed CD13, CD33 and DR; some expressed CD2, CD4 and CD34, The fluorescence in situ hybridization method revealed that bcr-abl fusion genes were absent from >90% of the bone marrow cells. The major bcr rearrangement was not detected by Southern blot analysis. We conclude that the leukaemic cells negative for Philadelphia chromosome may have developed as a result of treatment with alkylating agents and interferon in the present case.